Health For Life

“Based on the Phase 1 program, XOMA plans to initiate a multicenter, randomized , placebo- controlled Phase 2 program in Type 2 diabetes in the third quarter of 2009.” Nearly 100 patients were enrolled in Phase 1 trials in the U.S. and Switzerland

Here is the original:
PipelineReview.com – Biotech News & Online Store – Enrollment …